New Zealand's medicines regulator, Medsafe, approved two psychiatrists on September 4, 2026, to prescribe pharmaceutical-grade MDMA to patients with severe post-traumatic stress disorder

From the articleNew Zealand approves party-drug MDMA for treating patients with PTSDAlso in New Zealand approves use of party drug MDMA to treat trauma, New Zealand drugs regulator approves use of MDMA to treat severe PTSD